{"success":true,"data":{"pressRelease":{"id":"38052","rtpr_id":"nGNX6lDl6v","ticker":"ARVN","exchange":"NASDAQ","all_tickers":["ARVN"],"title":"Arvinas Employees Give Back During Company-wide Impact Day","author":"Globe Newswire","published_at":"2026-05-18T14:30:00.129Z","article_body":"NEW HAVEN, Conn., May 18, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq:\nARVN), a clinical-stage biotechnology company working to create a new class of\ndrugs based on targeted protein degradation, today announced that employees\nacross Connecticut, in the Greater Boston area, and around the country, took\npart in the Company’s fourth Arvinas Impact Day this past Friday. This\ncompany-wide day of service brings employees together to give back to their\ncommunities through volunteer activities that will make a meaningful\ndifference across the Greater New Haven area and beyond.\n\n“Impact Day is a meaningful reflection of our values at Arvinas, bringing\ntogether our commitment to patients and our desire to support the communities\nwhere we live and work,” said Randy Teel, Ph.D., President and CEO at\nArvinas. “I’m continually inspired by the passion and dedication of our\nemployees across the organization as they come together to make a tangible\ndifference. Their efforts highlight the strength of our culture and our shared\npurpose to create lasting impact for patients and communities alike.”\n\nThis year, employees participated in a range of organized volunteer projects\nfocused on preparing and serving meals to patients and their family members,\ncreating blankets for those experiencing hospital stays, and beautifying\nindoor and outdoor spaces to help make a measurable impact across multiple\ncommunities.\n\n“Volunteers like the Arvinas team help make a meaningful difference for the\nfamilies we aim to serve. By helping care for our spaces, they allow us to\nfocus on what matters most – providing comfort, support, and a sense of home\nfor families with children receiving medical care,” said Michelle D’Amore,\nChief Executive Officer, Ronald McDonald House Charities of Connecticut &\nWestern Massachusetts.\n\nHighlights from Arvinas Impact Day 2026 include: \n\n• Ronald McDonald House: Volunteers cleaned and organized indoor and outdoor\nspaces supporting families with children in need of medical care.\n\n• Fleece & Thank You: Employees created fleece blankets for children facing\nextended hospital stays, with opportunities to participate both remotely and\non-site in New Haven.\n\n• American Cancer Society Hope Lodge: Volunteers served meals to cancer\npatients and their caregivers in Boston, MA.\n\n• Save the Sound: Employees collected trash to help preserve and protect the\nLong Island Sound.\n\n• Boys & Girls Club of Greater New Haven: Teams supported facility\nbeautification efforts at locations in New Haven and Wallingford, CT.\n\n• Community Soup Kitchen: Employees prepared and served meals to members of\nthe New Haven community.\n\nAbout Arvinas\nArvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to\nimproving the lives of patients suffering from debilitating and\nlife-threatening diseases. Through its PROteolysis TArgeting Chimera (PROTAC)\nprotein degrader platform, Arvinas is pioneering the development of protein\ndegradation therapies designed to harness the body’s natural protein\ndisposal system to selectively and efficiently degrade and remove\ndisease-causing proteins. Arvinas is currently progressing multiple\ninvestigational drugs through clinical development programs, including\nARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting\nKRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small\ncell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin\nLymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or\npolyQ-AR, in skeletal muscle; and vepdegestrant, targeting the estrogen\nreceptor for patients with locally advanced or metastatic ER+/HER2- breast\ncancer. Arvinas is headquartered in New Haven, Connecticut. For more\ninformation about Arvinas, visit www.arvinas.com and connect on LinkedIn\n(https://www.globenewswire.com/Tracker?data=OR_yeVePGrP_nFCK2O6NFNAX9KBNmV301IVKZaIJTuWKY8UePXIZmdzCpvi2mebOuVcH9yWWbydGc76X7_ifh0rIXhEQX_0tElF6iky_4LaSZULA_wf5xLeMa5kA94g9fB6tnajwwqZjpZqcrqHYyzDpbAKBW8rHmg5y7C2zxlDUu2uwbAB0edtiOpv7Djok9UbwW05pDEEXfC5U10ErASsgoGo9z942GiFQGEpv0_Uvj5hPbx3gQJKEB42PEqOTqNHTnhe-_RhcxAmugoF8Rg==) and X\n(https://www.globenewswire.com/Tracker?data=9pMgVLfnIaHnpHrGPs9c9C2MCCCrAm7GC4lNqjudyHSTiNXPV770YD6QbJmd2j8Qvkkux4l3hw21iJ-qIsuyYiePZyUc48RRo2HvxEv29z2tBC1qb4XtZiIwBz5VZ9XN_Zpj_JGKX1MhQ_zXfcTHG0FLi7I3XW1F1Rrwn0hriMqFadHCssWUB6f9NRLeHamtGAc9JOS0gNTPZXDf8pWYEA==).\n\nArvinas Contacts \n\nInvestors:  \n\nJeff Boyle \n347-247-5089 \nJeff.Boyle@arvinas.com \n\nMedia: \nAlyssa Kuciunas \n331-481-3751  \nAlyssa.Kuciunas-c@arvinas.com \n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/563780a0-f8d9-4e37-8665-b622ef2caa5b)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX6lDl6v","title":"Arvinas Employees Give Back During Company-wide Impact Day","author":"Globe Newswire","ticker":"ARVN","created":"2026-05-18T14:30:00.129Z","tickers":["ARVN"],"exchange":"NASDAQ","article_body":"NEW HAVEN, Conn., May 18, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq:\nARVN), a clinical-stage biotechnology company working to create a new class of\ndrugs based on targeted protein degradation, today announced that employees\nacross Connecticut, in the Greater Boston area, and around the country, took\npart in the Company’s fourth Arvinas Impact Day this past Friday. This\ncompany-wide day of service brings employees together to give back to their\ncommunities through volunteer activities that will make a meaningful\ndifference across the Greater New Haven area and beyond.\n\n“Impact Day is a meaningful reflection of our values at Arvinas, bringing\ntogether our commitment to patients and our desire to support the communities\nwhere we live and work,” said Randy Teel, Ph.D., President and CEO at\nArvinas. “I’m continually inspired by the passion and dedication of our\nemployees across the organization as they come together to make a tangible\ndifference. Their efforts highlight the strength of our culture and our shared\npurpose to create lasting impact for patients and communities alike.”\n\nThis year, employees participated in a range of organized volunteer projects\nfocused on preparing and serving meals to patients and their family members,\ncreating blankets for those experiencing hospital stays, and beautifying\nindoor and outdoor spaces to help make a measurable impact across multiple\ncommunities.\n\n“Volunteers like the Arvinas team help make a meaningful difference for the\nfamilies we aim to serve. By helping care for our spaces, they allow us to\nfocus on what matters most – providing comfort, support, and a sense of home\nfor families with children receiving medical care,” said Michelle D’Amore,\nChief Executive Officer, Ronald McDonald House Charities of Connecticut &\nWestern Massachusetts.\n\nHighlights from Arvinas Impact Day 2026 include: \n\n• Ronald McDonald House: Volunteers cleaned and organized indoor and outdoor\nspaces supporting families with children in need of medical care.\n\n• Fleece & Thank You: Employees created fleece blankets for children facing\nextended hospital stays, with opportunities to participate both remotely and\non-site in New Haven.\n\n• American Cancer Society Hope Lodge: Volunteers served meals to cancer\npatients and their caregivers in Boston, MA.\n\n• Save the Sound: Employees collected trash to help preserve and protect the\nLong Island Sound.\n\n• Boys & Girls Club of Greater New Haven: Teams supported facility\nbeautification efforts at locations in New Haven and Wallingford, CT.\n\n• Community Soup Kitchen: Employees prepared and served meals to members of\nthe New Haven community.\n\nAbout Arvinas\nArvinas (Nasdaq: ARVN) is a clinical-stage biotechnology company dedicated to\nimproving the lives of patients suffering from debilitating and\nlife-threatening diseases. Through its PROteolysis TArgeting Chimera (PROTAC)\nprotein degrader platform, Arvinas is pioneering the development of protein\ndegradation therapies designed to harness the body’s natural protein\ndisposal system to selectively and efficiently degrade and remove\ndisease-causing proteins. Arvinas is currently progressing multiple\ninvestigational drugs through clinical development programs, including\nARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting\nKRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small\ncell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin\nLymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or\npolyQ-AR, in skeletal muscle; and vepdegestrant, targeting the estrogen\nreceptor for patients with locally advanced or metastatic ER+/HER2- breast\ncancer. Arvinas is headquartered in New Haven, Connecticut. For more\ninformation about Arvinas, visit www.arvinas.com and connect on LinkedIn\n(https://www.globenewswire.com/Tracker?data=OR_yeVePGrP_nFCK2O6NFNAX9KBNmV301IVKZaIJTuWKY8UePXIZmdzCpvi2mebOuVcH9yWWbydGc76X7_ifh0rIXhEQX_0tElF6iky_4LaSZULA_wf5xLeMa5kA94g9fB6tnajwwqZjpZqcrqHYyzDpbAKBW8rHmg5y7C2zxlDUu2uwbAB0edtiOpv7Djok9UbwW05pDEEXfC5U10ErASsgoGo9z942GiFQGEpv0_Uvj5hPbx3gQJKEB42PEqOTqNHTnhe-_RhcxAmugoF8Rg==) and X\n(https://www.globenewswire.com/Tracker?data=9pMgVLfnIaHnpHrGPs9c9C2MCCCrAm7GC4lNqjudyHSTiNXPV770YD6QbJmd2j8Qvkkux4l3hw21iJ-qIsuyYiePZyUc48RRo2HvxEv29z2tBC1qb4XtZiIwBz5VZ9XN_Zpj_JGKX1MhQ_zXfcTHG0FLi7I3XW1F1Rrwn0hriMqFadHCssWUB6f9NRLeHamtGAc9JOS0gNTPZXDf8pWYEA==).\n\nArvinas Contacts \n\nInvestors:  \n\nJeff Boyle \n347-247-5089 \nJeff.Boyle@arvinas.com \n\nMedia: \nAlyssa Kuciunas \n331-481-3751  \nAlyssa.Kuciunas-c@arvinas.com \n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/563780a0-f8d9-4e37-8665-b622ef2caa5b)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-05-18T14:30:00.181420914Z","server_sent_at_ms":1779114600181},"received_at":"2026-05-18T14:30:00.240Z","source_url":null},"analysis":{"id":"27495","press_release_id":"38052","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"Arvinas employees participated in the company’s fourth annual Impact Day, engaging in volunteer service across Connecticut, the Greater Boston area, and other locations.\n\nActivities included serving meals at the American Cancer Society Hope Lodge, creating blankets for hospital patients, and beautifying spaces for the Ronald McDonald House and Boys & Girls Club.\n\nCEO Randy Teel stated the event reflects the company’s commitment to patients and community support, highlighting employee culture.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine CSR update; no material business impact."},"keyFigures":{},"quotedText":"Impact Day is a meaningful reflection of our values at Arvinas, bringing together our commitment to patients and our desire to support the communities where we live and work","namedEntities":{"people":[{"name":"Randy Teel","role":"President and CEO"},{"name":"Michelle D’Amore","role":"CEO, Ronald McDonald House Charities of Connecticut & Western Massachusetts"},{"name":"Jeff Boyle","role":"Investor Relations Contact"},{"name":"Alyssa Kuciunas","role":"Media Contact"}],"products":["ARV-102","ARV-806","ARV-393","ARV-027","vepdegestrant","PROteolysis TArgeting Chimera (PROTAC)"],"companies":[{"name":"Arvinas, Inc.","ticker":"ARVN"},{"name":"Ronald McDonald House Charities of Connecticut & Western Massachusetts","relationship":"charity partner"},{"name":"American Cancer Society Hope Lodge","relationship":"charity partner"},{"name":"Save the Sound","relationship":"charity partner"},{"name":"Boys & Girls Club of Greater New Haven","relationship":"charity partner"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"This is a corporate social responsibility (CSR) announcement regarding employee volunteer activities. It contains no financial, operational, or clinical data that impacts valuation or business trajectory."},"tickerRelevance":{"others":[],"primary":"ARVN"},"globalImportance":5,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap_biotech","eventGravity":"csr_community_service","issuerAuthored":true,"financialImpact":"none"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Arvinas employees participated in the company’s fourth annual Impact Day, engaging in volunteer service across Connecticut, the Greater Boston area, and other locations.\n\nActivities included serving meals at the American Cancer Society Hope Lodge, creating blankets for hospital patients, and beautifying spaces for the Ronald McDonald House and Boys & Girls Club.\n\nCEO Randy Teel stated the event reflects the company’s commitment to patients and community support, highlighting employee culture.","key_figures":{},"named_entities":{"people":[{"name":"Randy Teel","role":"President and CEO"},{"name":"Michelle D’Amore","role":"CEO, Ronald McDonald House Charities of Connecticut & Western Massachusetts"},{"name":"Jeff Boyle","role":"Investor Relations Contact"},{"name":"Alyssa Kuciunas","role":"Media Contact"}],"products":["ARV-102","ARV-806","ARV-393","ARV-027","vepdegestrant","PROteolysis TArgeting Chimera (PROTAC)"],"companies":[{"name":"Arvinas, Inc.","ticker":"ARVN"},{"name":"Ronald McDonald House Charities of Connecticut & Western Massachusetts","relationship":"charity partner"},{"name":"American Cancer Society Hope Lodge","relationship":"charity partner"},{"name":"Save the Sound","relationship":"charity partner"},{"name":"Boys & Girls Club of Greater New Haven","relationship":"charity partner"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-18T14:30:18.826Z","global_importance":5,"audience_relevance":10,"importance_components":{"tickerTier":"mid-cap_biotech","eventGravity":"csr_community_service","issuerAuthored":true,"financialImpact":"none"}},"durationMs":18569,"modelName":"george-droid-qwen-72b"}}